Article info
Letter
Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis
- Correspondence to Dr Giacomo Emmi, Viale L.go Giovanni Brambilla, 3, 50134, Firenze, Italy; giacomaci{at}yahoo.it
Citation
Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis
Publication history
- Received June 6, 2017
- Revised August 2, 2017
- Accepted August 5, 2017
- First published August 16, 2017.
Online issue publication
April 11, 2023
Article Versions
- Previous version (2 May 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.